Alessio Bruni
University of Modena and Reggio Emilia
Quality of lifeInternal medicineRadiologyUrologySurgeryOncologyRetrospective cohort studyMedical physicsObservational studyLung cancerChemotherapyTomotherapyLungMetastasisConcomitantProstatectomyProstate cancerRadiosurgeryNuclear medicineStereotactic body radiotherapyIn patientRadiation therapyBreast cancerMedicine
84Publications
15H-index
443Citations
Publications 83
Newest
#1Sebastiano ButiH-Index: 24
#2Melissa Bersanelli (University of Parma)H-Index: 19
Last. Nunziata D'AbbieroH-Index: 6
view all 20 authors...
Abstract Objectives stereotactic body radiation therapy (SBRT) use has increased overtime for the management of metastatic renal cell carcinoma (mRCC) patients, with a likely good control of irradiated lesions. We planned a retrospective multicenter Italian study, with the aim of investigating the outcome of treatment with SBRT for non-brain secondary lesions in mRCC patients. Methods all consecutive metastatic non-brain lesions from mRCC that underwent SBRT at nine Italian institutions from Jan...
2 CitationsSource
#1Vieri ScottiH-Index: 19
#2Alessio BruniH-Index: 15
Last. Lorenzo LiviH-Index: 28
view all 8 authors...
Source
#1A. CiarmatoriH-Index: 7
#2N. Maffei (UNITO: University of Turin)H-Index: 5
Last. Gabriele GuidiH-Index: 10
view all 11 authors...
Abstract Parotid gland (PG) shrinkage and neck volume reduction during radiotherapy of head and neck (H&N) cancer patients is a clinical issue that has prompted interest in adaptive radiotherapy (ART). This study focuses on the difference between planned dose and delivered dose and the possible effects of an efficient replanning strategy during the course of treatment. Six patients with H&N cancer treated by tomotherapy were retrospectively enrolled. Thirty daily dose distributions (DMVCT) were ...
2 CitationsSource
#1Elise De Bleser (Ghent University Hospital)H-Index: 6
#2Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 36
Last. Piet Ost (UGent: Ghent University)H-Index: 41
view all 32 authors...
Abstract Background Stereotactic body radiotherapy (SBRT) and elective nodal radiotherapy (ENRT) are being investigated as metastasis-directed treatments in oligorecurrent prostate cancer (PC); however, comparative data are still lacking. Objective To compare outcome and toxicity between both treatments. Primary endpoint was metastasis-free survival, adjusted for selected variables (aMFS). Design, setting, and participants This was a multi-institutional, retrospective analysis of 506 (SBRT: 309,...
38 CitationsSource
#1Alessio Bruni (University of Modena and Reggio Emilia)
#1Alessio BruniH-Index: 15
Last. Vieri ScottiH-Index: 19
view all 26 authors...
: Concurrent chemotherapy and radiotherapy (cCRT) is considered the standard treatment of locally advanced non-small cell lung cancer (LA-NSCLC). Unfortunately, management is still heterogeneous across different specialists. A multidisciplinary approach is needed in this setting due to recent, promising results obtained by consolidative immunotherapy. The aim of this survey is to assess current LA-NSCLC management in Italy. From January to April 2018, a 15-question survey focusing on diagnostic/...
3 CitationsSource
#1Michela BuglioneH-Index: 21
#2Marianna Noale (National Research Council)H-Index: 24
Last. Luca TriggianiH-Index: 15
view all 23 authors...
Background There are several treatments available to newly diagnosed prostate cancer (PCA) patients. Although surgery and radiotherapy (RT) with or without androgen deprivation therapy (ADT) are widely adopted treatment options for localized PCA together with active surveillance (AS), there is no consensus nor randomised trials on treatment selection, prospective quality of life (QOL), along with toxicity outcomes and according to treatment modality in the Italian population. The current study a...
2 CitationsSource
#1M. Giaj LevraH-Index: 3
#1M. Giaj LevraH-Index: 4
Last. Benjamin Besse (Institut Gustave Roussy)H-Index: 78
view all 21 authors...
Source
#2Ahmed EissaH-Index: 8
Last. Bernardo RoccoH-Index: 33
view all 15 authors...
Source
#1Cristina Masini (AUSL: Academy for Urban School Leadership)H-Index: 17
#2Patrizia Ciammella (AUSL: Academy for Urban School Leadership)H-Index: 14
Last. Carmine PintoH-Index: 31
view all 20 authors...
Abstract Background NIVO is an anti-programmed cell death-1 (PD-1) monoclonal antibody; it might work even better when combined with SBRT improving clinical outcomes with a phenomenon known as abscopal effect. To date there are limited data on safety profile of combined SBRT and NIVO in mRCC. We report for the first time the toxicities occurred in phase II NIVES Study. Methods This is a phase II, single arm, multicentre study in pts with mRCC with progression disease after≤2 prior anti-angiogeni...
Source
#1Alessio BruniH-Index: 15
#2Patrizia CiammellaH-Index: 14
Last. Vieri ScottiH-Index: 19
view all 18 authors...
Source